These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14675575)

  • 1. Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis.
    Shirai K; Lansky AJ; Mintz GS; Costantini CO; Fahy M; Mehran R; Dangas G; Moses JW; Stone GW; Waksman R; Leon MB
    Am J Cardiol; 2003 Dec; 92(12):1409-13. PubMed ID: 14675575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions.
    Costantini CO; Lansky AJ; Mintz GS; Shirai K; Dangas G; Mehran R; Fahy M; Slack S; Coral M; Teirstein PS; Waksman R; Stone G; Moses J; Leon MB
    J Am Coll Cardiol; 2003 May; 41(10):1725-31. PubMed ID: 12767655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes.
    Suntharalingam M; Laskey WK; Tantibhedhyangkul W; Lansky A; Teirstein P; Bass T; Silber S; Rutherford B; Wilmer C; Popma JJ; Kuntz R; Bonan R
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):536-42. PubMed ID: 12957267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry.
    Suntharalingam M; Laskey W; Lansky AJ; Waksman R; White L; Teirstien P; Massullo V; Rutherford B; Elman A; Kuntz RE; Popma JJ; Bonan R
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1075-82. PubMed ID: 11958904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and angiographic one-year follow-up of vascular beta-brachytherapy for coronary lesions treated by a stent with a very high risk for restenosis].
    Schiele TM; Pöllinger B; Kantlehner R; Dühmke E; Theisen K; Klauss V
    Dtsch Med Wochenschr; 2003 May; 128(20):1103-8. PubMed ID: 12748899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy.
    Ortolani P; Marzocchi A; Aquilina M; Gaiba W; Neri S; Bunkheila F; Lombardo E; Pini S; Marrozzini C; Palmerini T; Taglieri N; Sbarzaglia P; Reggiani ML; Barbieri E; Branzi A
    Catheter Cardiovasc Interv; 2004 Dec; 63(4):433-8. PubMed ID: 15558757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of lesion length and reference vessel diameter on angiographic restenosis and target vessel revascularization in treating in-stent restenosis with radiation.
    Ajani AE; Waksman R; Cha DH; Gruberg L; Satler LF; Pichard AD; Kent KM
    J Am Coll Cardiol; 2002 Apr; 39(8):1290-6. PubMed ID: 11955846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial.
    Alli OO; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA; Holmes DR;
    Am Heart J; 2012 Mar; 163(3):438-45. PubMed ID: 22424015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.
    Iofina E; Radke PW; Skurzewski P; Haager PK; Blindt R; Koch KC; Hanrath P; vom Dahl J; Hoffmann R
    Heart; 2005 Dec; 91(12):1584-9. PubMed ID: 15797938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of shear stress with in-stent restenosis: bare metal stenting and the effect of brachytherapy.
    Papafaklis MI; Bourantas CV; Theodorakis PE; Katsouras CS; Fotiadis DI; Michalis LK
    Int J Cardiol; 2009 May; 134(1):25-32. PubMed ID: 18556077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of randomized controlled trials of intracoronary gamma- and beta-radiation therapy for in-stent restenosis.
    Uchida T; Bakhai A; Almonacid A; Shibata T; Cox B; Kuntz RE
    Heart Vessels; 2006 Nov; 21(6):368-74. PubMed ID: 17143713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries.
    Ferrero V; Ribichini F; Heyndrickx GR; De Bruyne B; Piessens M; Carlier S; Büchi M; Matullo G; Vassanelli C; Wijns W
    Am J Cardiol; 2004 Nov; 94(10):1237-42. PubMed ID: 15541237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial intravascular ultrasound analysis after intracoronary beta-radiation in long in-stent restenotic lesions.
    Schiele TM; Zimmermann A; Rieber J; König A; Krötz F; Sohn HY; Kantlehner R; Pöllinger B; Dühmke E; Theisen K; Bauriedel G; Klauss V
    Z Kardiol; 2002; 91 Suppl 3():17-22. PubMed ID: 12641011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use.
    Kim S; Almeda FQ; Tessalee M; Snell RJ; Nathan S; Thew S; Nguyen C; Chu JC; Schaer GL
    Cardiovasc Radiat Med; 2004; 5(1):9-14. PubMed ID: 15275626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular brachytherapy versus drug-eluting stents in the treatment of in-stent restenosis: A meta-analysis of long-term outcomes.
    Benjo A; Cardoso RN; Collins T; Garcia D; Macedo FY; El-Hayek G; Nadkarni G; Aziz E; Jenkins JS
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):200-8. PubMed ID: 25963829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional stenting promotes intimal proliferation and compromises the results of intravascular radiation therapy: an intravascular ultrasound study.
    Cheneau E; Wu Z; Leborgne L; Ajani AE; Weissman N; Pichard AD; Satler LF; Kent KM; Mintz G; Waksman R
    Am Heart J; 2003 Jul; 146(1):142-5. PubMed ID: 12851623
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.